Key facts
- This page summarizes Weird Science LLC's Form 4 filing for Enochian Biosciences Inc (RENB).
- 8 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Feb 2023, 18:24.
Weird Science LLC - 16 Feb 2018 Form 4 Insider Report for Enochian Biosciences Inc (RENB)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- RENB
- Reported as of
- 16 Feb 2018
- Net transaction value
- $0
- Reporting owner signature
- /s/ William Anderson Wittekind, as Manager
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Weird Science LLC filed Form 4 for Enochian Biosciences Inc (RENB) on 06 Feb 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RENB
transaction
Common Stock
Other
- Transaction value
- Shares
- +17,545,283
- Change %
- Price
- Shares after
- 17,545,283
- Date
- 16 Feb 2018
- Ownership
- Direct
- Footnotes
- F1
RENB
transaction
Common Stock
Other
- Transaction value
- Shares
- +1,268,880
- Change %
- +7.2%
- Price
- Shares after
- 18,814,163
- Date
- 31 Dec 2018
- Ownership
- Direct
- Footnotes
- F2
RENB
transaction
Common Stock
Other
- Transaction value
- Shares
- +3,631,234
- Change %
- +19%
- Price
- Shares after
- 22,445,397
- Date
- 30 Jul 2019
- Ownership
- Direct
- Footnotes
- F2
RENB
transaction
Common Stock
Other
- Transaction value
- Shares
- -17,545,283
- Change %
- -78%
- Price
- Shares after
- 4,900,114
- Date
- 29 May 2020
- Ownership
- Direct
- Footnotes
- F3
RENB
transaction
Common Stock
Other
- Transaction value
- Shares
- +61,249
- Change %
- +1.2%
- Price
- Shares after
- 4,961,363
- Date
- 14 Dec 2020
- Ownership
- Direct
- Footnotes
- F2
RENB
transaction
Common Stock
Other
- Transaction value
- Shares
- +97,032
- Change %
- +2%
- Price
- Shares after
- 5,058,395
- Date
- 11 Apr 2022
- Ownership
- Direct
- Footnotes
- F2
RENB
transaction
Common Stock
Other
- Transaction value
- Shares
- -4,961,363
- Change %
- -98%
- Price
- Shares after
- 97,032
- Date
- 15 Apr 2022
- Ownership
- Direct
- Footnotes
- F3
RENB
transaction
Common Stock
Other
- Transaction value
- Shares
- +1,216,467
- Change %
- +1254%
- Price
- Shares after
- 1,313,499
- Date
- 13 Oct 2022
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Weird Science LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
The Reporting Person received these shares as merger consideration in exchange for the Reporting Person's common stock of Enochian BioPharma, Inc., which the Issuer acquired by merger on February 16, 2018. In addition to such shares, the Agreement and Plan of Merger governing the merger (the "Merger Agreement") provides that upon the exercise or conversion of options and warrants to purchase shares of the Issuer's common stock that were outstanding as of the closing of the merger, the Issuer will issue a like number of shares of Common Stock (referred to as "Earn-Out Stock") to the former stockholders of Enochian BioPharma, Inc., including the Reporting Person, on a pro rata basis. The Reporting Person's right to receive additional shares of the Issuer's common stock as Earn-Out Stock became fixed and irrevocable on February 16, 2018, the closing date of the merger.
Footnote F2
Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement.
Footnote F3
Pro rata distribution to the members of the Reporting Person.